The Activity of Crizotinib in Chemo-Refractory MET-Amplified Esophageal and Gastric Adenocarcinomas: Results from the AcSé-Crizotinib Program.

Thomas AparicioNathalie CozicChristelle de la FouchardièreEmeline MeriauxJérome PlazaLaurent MineurRosine GuimbaudEmmanuelle SamalinFlorence MaryThierry LecomteCarlos Gomez-RocaPaul-Arthur HaineauxAlain GratetJannick SelvesYves MenuNikias ColignonLaetitia JohnsonFrédéric LegrandGilles Vassal

Published in: Targeted oncology (2021)

14 January 2014.

Keyphrases

advanced non small cell lung cancer
acute coronary syndrome
photodynamic therapy
quality improvement
tyrosine kinase
epidermal growth factor receptor
cancer therapy
locally advanced
combination therapy
radiation therapy
squamous cell carcinoma